NKTR position history
The shares of Nektar Therapeutics (NKTR) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 10,000 shares, $258K, 0.07% of portfolio, New
- 2025 Q3: 54,998 shares, $3.1M, 0.77% of portfolio, Add +450.0%
- 2025 Q4: 74,998 shares, $3.2M, 0.74% of portfolio, Add +36.4%
- 2026 Q1: 165,178 shares, $12M, 2.7% of portfolio, Add +120.2%
- 2026 Q2: 318,380 shares, $22M, 4.2% of portfolio, Add +92.7%
- 2026 Q3: 323,380 shares, $20M, 4.2% of portfolio, Add +1.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|